Evidence map›Paper›PMID 41649747›Full record

ArticleTherapeutic innovation & regulatory science2026

Quantifying Eligibility Pattern Shifts: a Data-Driven Paradigm for Early Risk Detection in Clinical Trials.

Atanu Bhattacharjee, Ayon Mukherjee

Abstract read
In one paragraph

Article in Therapeutic innovation & regulatory science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Atanu BhattacharjeeDivision of Population Health and Genomics, University of Dundee, Dundee, United Kingdom.
Ayon Mukherjee *Population Health Sciences Institute, Newcastle University, Newcastle, United Kingdom. ayon.mukherjee@newcastle.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional Risk-Based Monitoring (RBM) strategies emphasise key risk indicators and site-level performance metrics but seldom address the heterogeneity of patient eligibility profiles. We present a data-driven framework that captures temporal and inter-site shifts in baseline inclusion characteristics. Central to this framework are two new metrics-Borderline Inclusion Index and Eligibility Distribution Divergence-that quantify departures from expected enrolment patterns. A Bayesian composite score synthesises these indicators to prioritise oversight actions. Through simulation experiments and a worked case study, we show that monitoring eligibility pattern shifts offers an early warning signal of operational or scientific risk and strengthens overall trial integrity. We operationalize the framework through an interactive Shiny web application that computes indicator-specific posteriors, generates composite site risk scores, and provides visual decision-support for centralized RBM implementation.

Indexed as

Clinical Trials as TopicEligibility DeterminationPatient SelectionBayes TheoremComputer SimulationHumansRisk AssessmentAdaptive OversightBaseline Inclusion CriteriaBayesian Monitoring FrameworkCentralized MonitoringClinical Trial Quality AssuranceEligibility HeterogeneityEnrollment Pattern ShiftRisk-Based Monitoring (RBM)Shiny Decision-Support ToolSite-Level Risk Assessment

Identifiers

PMID41649747
PMCPMC13110207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.